about
Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens.Rapid regulation of depression-related behaviours by control of midbrain dopamine neuronsβ-catenin mediates stress resilience through Dicer1/microRNA regulationSerotonin mediates CA1 spine density but is not crucial for ovarian steroid regulation of synaptic plasticity in the adult rat dorsal hippocampusNuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behaviorBDNF is a negative modulator of morphine action.Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors.Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental areaSIRT1-FOXO3a regulate cocaine actions in the nucleus accumbens.Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental areaKappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats.IκB kinase regulates social defeat stress-induced synaptic and behavioral plasticityDishevelled-2 regulates cocaine-induced structural plasticity and Rac1 activity in the nucleus accumbens.Serum response factor and cAMP response element binding protein are both required for cocaine induction of ΔFosB.A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesiaRole of Tet1 and 5-hydroxymethylcytosine in cocaine action.Anti-glucocorticoid gene therapy reverses the impairing effects of elevated corticosterone on spatial memory, hippocampal neuronal excitability, and synaptic plasticityRac1 is essential in cocaine-induced structural plasticity of nucleus accumbens neuronsViral vector-mediated blockade of the endocrine stress-response modulates non-spatial memory.SIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens.Essential role of SIRT1 signaling in the nucleus accumbens in cocaine and morphine action.Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB.Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway.Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.A silent synapse-based mechanism for cocaine-induced locomotor sensitization.Mineralocorticoid receptor overexpression in basolateral amygdala reduces corticosterone secretion and anxiety.Erratum to: Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens.Short toxic methamphetamine schedule impairs object recognition task in male rats.Effects of chronic restraint stress and estradiol on open field activity, spatial memory, and monoaminergic neurotransmitters in ovariectomized rats.Chronic D-amphetamine induces sexually dimorphic effects on locomotion, recognition memory, and brain monoamines.Enhancing cognition after stress with gene therapy.Restructuring the neuronal stress response with anti-glucocorticoid gene delivery.Changes in cerebrospinal fluid neurochemistry during pregnancy.Mineralocorticoid receptor overexpression differentially modulates specific phases of spatial and nonspatial memory.Overexpression of mineralocorticoid and transdominant glucocorticoid receptor blocks the impairing effects of glucocorticoids on memory.Cocaine Mediates the Cellular Mechanism of Satiation.
P50
Q21999524-B38FABCC-1912-4900-8F6A-ECEBC3D1C701Q24630584-EB8DF4EF-F523-4ABA-8CF9-F8D92DDFC639Q28251285-5E5AF37F-F14B-45DB-8341-72C54659A09AQ28569022-AE4ED5F0-708B-475C-958C-13C495065AB7Q33664173-2DF6AD3F-49E7-4381-8193-364495D34F50Q34304358-1DE854F4-257D-421F-AF41-09BD22AD62FEQ34560157-AE81574D-02DD-4FFF-A219-8CABE7F1B6ECQ34995907-9B4F07F2-45C2-46B2-A1E1-58A6A0F6A7C2Q35092686-3E1C5101-D96D-4F71-A2B1-7F5B49CDB698Q35122229-102E057D-171F-4292-9A1E-8B01A2B9969EQ35147542-21314319-D86F-49C8-BFFA-C3854A4EF207Q35558426-5DA6643D-C026-4230-B4E4-5A83676DFAD7Q35685372-A7FECE59-248E-49AC-8C31-86684D8B150DQ36019392-B9BD95BD-6DE1-4FC1-BC6E-8DF2920740ABQ36141986-13AC61E8-5B32-447D-B0CF-38F3027AA344Q36197525-AD7C8E06-3E44-490C-9CDE-FF152AB031DBQ36451348-AF5E0B1D-A501-4510-84C0-826805ED385DQ36590613-2047216C-46D4-4CCD-B28C-B02155679FACQ36803176-ED1DE597-271E-46FF-9663-9B7B3DA8F9B5Q37162737-A4CE830F-EE36-47FE-819A-8BB9887DB6A3Q37220050-013742B5-45CB-49B5-A076-07A933394930Q37633608-5E711580-D85F-4C08-8E4C-D40B3C465CA2Q38725380-6157785B-21E1-4BF1-9CFC-71122AC6AD3EQ40777843-B064C92E-83E2-4F40-8F7D-3560B6401595Q41518514-72708055-2383-4B5B-8A1B-EFB5E1B3E95CQ42454948-5DA21FF2-7A39-4A04-B4B9-44ACC121EBE2Q43223049-B5A8692A-46B9-448A-B145-4BFED0C56827Q44000359-85A5EB9E-4246-4536-BC2A-459B77086ACFQ44070782-6166454D-2EB0-4BB5-A02A-0C2CB414684FQ44384959-15BA84D9-89B6-43F7-B517-FCE4A0D80912Q44642200-35B26A9A-ACE9-4655-8438-BDBB2C433B2EQ45010724-AE07ADC0-CD62-4438-837A-531E897E4B28Q45056369-59028332-A63F-4CDD-8DE9-2F772BB45A43Q45942767-4C7D0C0E-72C8-4875-95E0-B8ABA23F0E78Q46293078-8FB5FC5D-3E3B-4578-B785-082F697CF235Q50451476-1D4D5D00-10B1-402A-AB30-ADBAFFA1DB47
P50
description
American molecular geneticist
@en
xenetista molecular estauxunidense
@ast
name
Deveroux Ferguson
@ast
Deveroux Ferguson
@ca
Deveroux Ferguson
@en
Deveroux Ferguson
@es
Deveroux Ferguson
@fr
Deveroux Ferguson
@nl
Deveroux Ferguson
@sl
type
label
Deveroux Ferguson
@ast
Deveroux Ferguson
@ca
Deveroux Ferguson
@en
Deveroux Ferguson
@es
Deveroux Ferguson
@fr
Deveroux Ferguson
@nl
Deveroux Ferguson
@sl
prefLabel
Deveroux Ferguson
@ast
Deveroux Ferguson
@ca
Deveroux Ferguson
@en
Deveroux Ferguson
@es
Deveroux Ferguson
@fr
Deveroux Ferguson
@nl
Deveroux Ferguson
@sl
P1153
7402014090
P1960
A8T_j2kAAAAJ
P2038
Deveroux_Ferguson2
P21
P31
P496
0000-0001-9302-5992